*Includes partial introduction

Slides:

Advertisements

Similar presentations

Update on Vaccines not Included in this Tender: Rotavirus Vaccines Pre Tender Meeting UNICEF Supply Division, 10-11th December 2008 Ann Ottosen.

Advertisements

Demo Script CCEM: Cold Chain Equipment Manager Version December 1, /28/20101CCEM

Vaccine in National Immunization Programme Update March 2015.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.

World Health Organization

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Module 3 Inactivated poliovirus vaccine eligibility Training for Inactivated Poliovirus Vaccine (IPV) introduction.

Immunobiology: The Immune System in Health & Disease Sixth Edition

TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.

Impact of the Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease (IPD) in Ireland Data source: National Pneumococcal.

World Health Organization

Global Immunization Performance Update through 2011.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.

Modeling of the effect of pneumococcal conjugate vaccination on carriage and transmission of Streptococcus pneumoniae in Kenyan children John Ojal KEMRI-Wellcome.

The changing vaccination landscape and the sources of vaccination data

EUROPE Nov 27 –Dec 10 November 27 - Dec 10.

GREAT PLAINS AREA 2014 GPRA FINAL RESULTS & BEST PRACTICES Janelle Trottier, MSW, LCSW Health Systems Specialist.

Molecular Biology of the Cell Fifth Edition Molecular Biology of the Cell Fifth Edition Chapter 25 The Adaptive Immune System Chapter 25 The Adaptive Immune.

Improving Pneumococcal Vaccination Rates David Diamant MD, Molly Benedum MD Center for Family Medicine Aim The aim is to increase awareness of pneumococcal.

Vaccine in National Immunization Programme Update April 2016.

Date of download: 9/17/2016 From: Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United.

Global summary of the HIV and AIDS epidemic, December 2003

World Health Organization

Ann Intern Med. 2007;147(10): doi: / Figure Legend:

Formation Date: 9 November 1977 Geo Code: R

Downtown Community Health Centre

Recommended Timeline for Influenza Vaccinations

Progress and Challenges with achieving Universal Immunization Coverage

World Health Organization

خشنه اتره اهورهه مزدا شيوۀ ارائه مقاله 17/10/1388.

Global summary of the HIV and AIDS epidemic, December 2004

What’s new in 2010? (cont) New PCV 13 recommendations

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

World Health Organization

Using Dynamic Transmission Modeling to Determine Vaccination Coverage Rate Based on 5-Year Economic Burden of Infectious Disease: An Example of Pneumococcal.

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era S. Nunes,

Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation Joseph H. Antin, Eva C. Guinan,

K. Luthra1, A. Zimmermann Jin2,3, P. Vasudevan1, L. Privor-Dumm1

When less is more: how many doses of PCV are enough?

Heterotaxy syndrome with and without spleen: Different infection risk and management Eva Piano Mortari, PhD, Anwar Baban, MD, PhD, Nicoletta Cantarutti,

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era S. Nunes,

The role of vaccination in preventing pneumococcal disease in adults

Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis Dr Tinevimbo.

Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.

World Health Organization

World Health Organization

Assessment of herd immunity from human papillomavirus vaccination

Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes S. Ladhani,

Can we control all-cause meningococcal disease in Europe?

Daniel M. Musher, MD Mayo Clinic Proceedings

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort.

Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989–2008) C. Esteva, L. Selva, M.F.

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational.

Clinical Microbiology and Infection

Sensitivity to immunity parameters.

Thing / Person:____________________ Dates:_________________

Formation Date: 9 November 1977 Geo Code: R

Formation Date: 20 November 1993 Geo Code: R

Data source: Irish Pneumococcal Reference Laboratory

2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)

World Health Organization

Abbreviations: CMV, cytomegalovirus; IgG, immunoglobulin G.

World Health Organization

Invasive Pneumococcal Disease Serotypes After the Introduction of Pneumococcal Seven-Valent Conjugate Vaccine Arizona, Susan Goodykoontz, Daniel.

Cost-effectiveness acceptability curves.

Key pneumonia risk factors assessed during maternal postnatal interview. Key pneumonia risk factors assessed during maternal postnatal interview. EPI:

Presentation transcript:

*Includes partial introduction Figure 1. Countries with Pneumococcal Conjugate vaccine (PCV) in the national immunization program and planned introductions in 2016, adapted to include dates of introduction for PCV for selected countries, organized by WHO region World Health Organization. Immunization, Vaccines, and Biologicals-Data, statistics and graphics. Updated 01 December 2016. Available at http://www.who.int/immunization/monitoring_surveillance/data/en Accessed 7 December 2016. *Includes partial introduction Figure 1. Countries with Pneumococcal Conjugate vaccine (PCV) in the national immunization program and planned introductions in 2016, adapted to include dates of introduction for PCV for selected countries, organized by WHO region World Health Organization. Immunization, Vaccines, and Biologicals-Data, statistics and graphics. Updated… Infect Chemother. 2016 Dec;48(4):257-266. https://doi.org/10.3947/ic.2016.48.4.257